Innovation Acta

Innovation Acta is an Italian-based consultancy specializing in supporting the planning, execution, and management of European Union-funded research and innovation projects. It acts as a partner for public-private collaborations across life sciences—including biotechnology and pharmaceutical industry consortia—by providing expertise in grant writing, consortium building, project management, communication/dissemination activities, and administrative support. The company is involved with high-profile EU-funded initiatives such as geneTIGA (cell therapy for IgA nephropathy), PROTO (advanced cell therapies for osteoarthritis), LIVERAIM (biomarker-based platform for liver disease diagnosis), among others. However, it does not itself develop drugs or medical devices.